| Specialty Retail Industry | Consumer Discretionary Sector | Dr. Chandrashekhar Mainde CEO | XNSE Exchange | INE518E01015 ISIN |
| India Country | 577 Employees | 18 Jan 2022 Last Dividend | 22 Dec 2022 Last Split | - IPO Date |
ZIM Laboratories Limited is a prominent player in the pharmaceutical and nutraceutical industry, operating both in India and on an international scale. Since its establishment in 1984, the company has dedicated itself to the development, manufacturing, and supply of generic pharmaceutical products alongside nutraceutical items. With a base in Nagpur, India, ZIM Laboratories has carved a niche for itself by specializing in the production of a wide array of oral solid dosage forms. They're known for utilizing modified release patterns to enhance the effectiveness and patient compliance of their products.
ZIM Laboratories Limited offers an extensive range of products and services designed to cater to various therapeutic areas, utilizing advanced technology and innovative delivery systems. Their product offerings include: